UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

Nature communications, 2021-02, Vol.12 (1), p.1047-1047, Article 1047

2021

Volltextzugriff (PDF)

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

Journal of investigative dermatology, 2010-05, Vol.130 (5), p.1373-1383

2010

Volltextzugriff (PDF)

A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics

Analyst (London), 2022-09, Vol.147 (19), p.4275-4284

2022

Volltextzugriff (PDF)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms

Frontiers in immunology, 2022-06, Vol.13, p.939789-939789

2022

Volltextzugriff (PDF)

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002371

2021

Volltextzugriff (PDF)

142 Detection of KRAS G12D/G12V neoepitopes expressed by cancer cell lines using LC-MS/MS

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A162-A162

2023

Volltextzugriff (PDF)

Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e002663

2021

Volltextzugriff (PDF)

Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites

Journal for immunotherapy of cancer, 2024-01, Vol.12 (1), p.e007573

2024

Volltextzugriff (PDF)

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e000705

2020

Volltextzugriff (PDF)

149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A169-A169

2023

Volltextzugriff (PDF)

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e004033

2022

Volltextzugriff (PDF)

1487 PD-1 expression on tumor-infiltrating T-lymphocytes as determinant of the head and neck cancer tumor immune microenvironment rather than anatomical site

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1651-A1651

2023

Volltextzugriff (PDF)

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A168-A168

2023

Volltextzugriff (PDF)

Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells

PloS one, 2012-02, Vol.7 (2), p.e31296

2012

Volltextzugriff (PDF)

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer

NPJ breast cancer, 2023-06, Vol.9 (1), p.53-53, Article 53

2023

Volltextzugriff (PDF)

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A771-A771

2023

Volltextzugriff (PDF)

760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A455-A456

2020

Volltextzugriff (PDF)

399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A431-A431

2021

Volltextzugriff (PDF)

94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A103-A103

2021

Volltextzugriff (PDF)

CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE

International reviews of immunology, 2002, Vol.21 (4-5), p.423-428

2002

Volltextzugriff (PDF)

Activation of Vα14+ Natural Killer T Cells by α-Galactosylceramide Results in Development of Th1 Response and Local Host Resistance in Mice Infected with Cryptococcus neoformans

Infection and Immunity, 2001-01, Vol.69 (1), p.213-220

2001

Volltextzugriff (PDF)

A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral Blood

Immunological investigations, 2022-11, Vol.51 (8), p.2159-2175

2022

Volltextzugriff (PDF)

Immunological profiling of tumor-infiltrating CD8+ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.179-179.10

2022

Volltextzugriff (PDF)

Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.65-65.16

2022

Volltextzugriff (PDF)

Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.179-179.14

2022

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(38)
Immunology
(30)
Immunotherapy
(28)
Animals
(25)
Mice
(24)
Female
(19)
Cryptococcus Neoformans
(18)
Humans
(18)
Biological And Medical Sciences
(17)
Antigens
(15)
Infectious Diseases
(15)
Microbiology
(15)
Fundamental And Applied Biological Sciences. Psychology
(13)
Mice, Inbred C57bl
(13)
Cancer
(12)
Cryptococcus Neoformans - Immunology
(12)
Lymphocytes
(11)
Biomarkers
(10)
Il-12
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

142 Detection of KRAS G12D/G12V neoepitopes expressed by cancer cell lines using LC-MS/MS

Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

1487 PD-1 expression on tumor-infiltrating T-lymphocytes as determinant of the head and neck cancer tumor immune microenvironment rather than anatomical site

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE

Activation of Vα14+ Natural Killer T Cells by α-Galactosylceramide Results in Development of Th1 Response and Local Host Resistance in Mice Infected with Cryptococcus neoformans

A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral Blood

Immunological profiling of tumor-infiltrating CD8+ T lymphocytes in non-small cell lung cancer, head and neck squamous cell carcinoma, breast cancer, and renal cell cancer

Durability of B and T cell responses against a spike protein of SARS-CoV2 elicited by mRNA vaccines

Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy

Suchergebnisse filtern